In Cd36−/− mice receiving different cancer cell implants (murine Lewis lung carcinoma LCC cells, murine B16F10 melanoma cells, Hepa1-6 hepatoma cells, CT26 or MCA-38 colon cancer cells) tumor growth is reduced, and the number of metastases is decreased compared to WT mice (Al-Khami et al., 2017; Yang et al., 2022). Here, CD36 is linked to hepatocellular carcinoma.